Isolated single-lung perfusion with doxorubicin is pharmacokinetically superior to intravenous injection
- 31 August 1993
- journal article
- research article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 56 (2) , 209-214
- https://doi.org/10.1016/0003-4975(93)91149-h
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Isolated single lung perfusion in the rat: an experimental modelJournal of Applied Physiology, 1993
- Five-year survival after pulmonary metastasectomy for adult soft tissue sarcomaCancer, 1992
- A prospective randomized trial of adjuvant chemotherapy with bolus versus continuous infusion of doxorubicin in patients with high-grade extremity soft tissue sarcoma and an analysis of prognostic factorsCancer, 1991
- Pharmacokinetics and toxicity of isolated perfusion of lung with doxorubicinJournal of Surgical Research, 1991
- Response to chemotherapy does not predict survival after resection of sarcomatous pulmonary metastasesThe Annals of Thoracic Surgery, 1991
- Pulmonary toxicity of doxorubicin administered byin situ isolated lung perfusion in dogsCancer, 1988
- Comparative pharmacokinetics and metabolism of doxorubicin and 4-demethoxy-4?-O-methyldoxorubicin in tumor-bearing miceCancer Chemotherapy and Pharmacology, 1986
- Patterns of recurrence in patients with high-grade soft-tissue sarcomas.Journal of Clinical Oncology, 1985
- Selection by trypsin of two sublines of rat colon cancer cells forming progressive or regressive tumorsInternational Journal of Cancer, 1983
- Isolated lung perfusion with adriamycin. A preclinical studyCancer, 1983